AFP and hepatocellular carcinoma: The pooled sensitivity and specificity of AKR1B10 combined with AFP in discriminating HCC from non-HCC were 0.84 (95% CI: 0.79–0.88) and 0.88 (95% CI: 0.73–0.95), respectively.